{"title":"Glanzmann’s Thrombasthenia in the Parturient Undergoing Cesarean Delivery- A Case Report and Discussion of Clinical Consideration","authors":"","doi":"10.36879/apm.2021.000103","DOIUrl":null,"url":null,"abstract":"Glanzmann thrombasthenia (GT) is a rare hemorrhagic disorder characterized by the absence of IIb-IIIa platelet glycoprotein (GPIIbIIIa) on the platelet surface. Many GT patients experience recurrent bleeding and require frequent platelet transfusion. Therefore,\nthey are at risk for alloimmunization against platelet glycoprotein or Human leucocyte antigen (HLA) epitopes resulting in platelet\nrefractoriness and therapeutic failure. We report a unique case of GT in pregnancy at risk for severe postpartum hemorrhage due to\nanti-GP IIb/IIIa and anti-HLA antibodies and the use of pro-hemostatic agents to optimize outcomes. A multidisciplinary approach is\nessential to achieving the best possible outcomes for these patients.","PeriodicalId":92204,"journal":{"name":"Global anesthesia and perioperative medicine","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global anesthesia and perioperative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36879/apm.2021.000103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Glanzmann thrombasthenia (GT) is a rare hemorrhagic disorder characterized by the absence of IIb-IIIa platelet glycoprotein (GPIIbIIIa) on the platelet surface. Many GT patients experience recurrent bleeding and require frequent platelet transfusion. Therefore,
they are at risk for alloimmunization against platelet glycoprotein or Human leucocyte antigen (HLA) epitopes resulting in platelet
refractoriness and therapeutic failure. We report a unique case of GT in pregnancy at risk for severe postpartum hemorrhage due to
anti-GP IIb/IIIa and anti-HLA antibodies and the use of pro-hemostatic agents to optimize outcomes. A multidisciplinary approach is
essential to achieving the best possible outcomes for these patients.